Kymera Therapeutics, Inc. (KYMR)
USD 21.05
(-4.36%)
USD 21.05
(-4.36%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -110.48 Million USD | 71.1% |
| 2022 | 43.84 Million USD | -37.75% |
| 2021 | 70.43 Million USD | 350.92% |
| 2020 | -28.07 Million USD | -1431.01% |
| 2019 | 2.1 Million USD | 1128.78% |
| 2018 | -205 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 23.75 Million USD | 170.29% |
| 2024 Q3 | 1.74 Million USD | -92.67% |
| 2024 Q1 | 8.78 Million USD | -81.31% |
| 2023 Q4 | 47.02 Million USD | 1128.32% |
| 2023 FY | 75.02 Million USD | 71.1% |
| 2023 Q3 | 3.82 Million USD | -75.48% |
| 2023 Q2 | 15.61 Million USD | 82.27% |
| 2023 Q1 | 8.56 Million USD | -44.09% |
| 2022 Q2 | 10.81 Million USD | 12.39% |
| 2022 Q1 | 9.62 Million USD | -37.01% |
| 2022 FY | 43.84 Million USD | -37.75% |
| 2022 Q4 | 15.32 Million USD | 144.63% |
| 2022 Q3 | -34.32 Million USD | -417.42% |
| 2021 Q1 | 18.7 Million USD | 46.28% |
| 2021 Q2 | 18.51 Million USD | -0.98% |
| 2021 FY | 70.43 Million USD | 350.92% |
| 2021 Q4 | 15.27 Million USD | -24.89% |
| 2021 Q3 | 20.33 Million USD | 9.81% |
| 2020 Q4 | 12.78 Million USD | -12.03% |
| 2020 Q1 | 3.42 Million USD | 87.02% |
| 2020 Q3 | 14.53 Million USD | 342.0% |
| 2020 Q2 | 3.28 Million USD | -4.08% |
| 2020 FY | -28.07 Million USD | -1431.01% |
| 2019 Q3 | 950 Thousand USD | 0.0% |
| 2019 FY | 2.1 Million USD | 1128.78% |
| 2019 Q4 | 1.83 Million USD | 92.95% |
| 2018 FY | -205 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 191.712% |
| Jaguar Health, Inc. | 7.72 Million USD | 1530.463% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -16539.91% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -2209680.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 107.279% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 192.264% |
| ContextLogic Inc. | 59 Million USD | 287.269% |
| MiMedx Group, Inc. | 266.84 Million USD | 141.406% |
| MEI Pharma, Inc. | 49.32 Million USD | 323.993% |
| AlloVir, Inc. | -398 Thousand USD | -27661.055% |
| Novavax, Inc. | 639.93 Million USD | 117.266% |
| Aptorum Group Limited | -1.11 Million USD | -9812.101% |
| Ardelyx, Inc. | 106.66 Million USD | 203.589% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 145.897% |
| Psyence Biomedical Ltd. | -240.00 USD | -46036983.333% |
| Vaxcyte, Inc. | -75 Million USD | -47.319% |
| Precigen, Inc. | 106 Thousand USD | 104334.906% |
| Pharming Group N.V. | 220.1 Million USD | 150.199% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 21554.175% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 11050.347% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 200.653% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 39.094% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -21281.685% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 14.693% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -143.771% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -402.52% |
| Acelyrin, Inc. | -115 Thousand USD | -95977.391% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -19250.088% |
| Senti Biosciences, Inc. | -2.68 Million USD | -4018.114% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2827.45% |
| AbCellera Biologics Inc. | 38.02 Million USD | 390.569% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -2202.814% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 92174.167% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 479.309% |
| Chimerix, Inc. | 324 Thousand USD | 34201.543% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 22376.008% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -134642.683% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -254.499% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -22357.114% |
| Elevation Oncology, Inc. | -39 Thousand USD | -283205.128% |
| Alkermes plc | 1.37 Billion USD | 108.037% |
| Fortress Biotech, Inc. | 57.85 Million USD | 290.982% |
| Fortress Biotech, Inc. | 57.85 Million USD | 290.982% |
| Agenus Inc. | 139.61 Million USD | 179.138% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 766.52% |
| Dyadic International, Inc. | 922.95 Thousand USD | 12071.197% |
| ImmuCell Corporation | 4.39 Million USD | 2613.236% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 624.614% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -4.114% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -63093.265% |
| Immix Biopharma, Inc. | -5468.00 USD | -2020547.403% |
| Incyte Corporation | 3.44 Billion USD | 103.211% |
| IO Biotech, Inc. | -756 Thousand USD | -14514.947% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -135.891% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -727.147% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -249942.998% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -12.495% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -200789.091% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 13876.683% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -20865.655% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 475.979% |
| NextCure, Inc. | -3.68 Million USD | -2899.159% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 680.208% |
| Onconetix, Inc. | -1.12 Million USD | -9702.38% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -281.417% |
| Opthea Limited | 21.72 Thousand USD | 508797.053% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -192638.025% |
| PureTech Health plc | -1.6 Million USD | -6792.639% |
| Pyxis Oncology, Inc. | -2 Million USD | -5424.45% |
| Seer, Inc. | 7.02 Million USD | 1672.35% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1099183.653% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1503.748% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2702.832% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 26158.726% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 206.138% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 181.681% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -13.965% |
| ChromaDex Corporation | 50.78 Million USD | 317.584% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -47524.569% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -42.386% |
| CRISPR Therapeutics AG | 240.95 Million USD | 145.854% |
| Precision BioSciences, Inc. | 40.47 Million USD | 373.001% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -12.557% |
| Innoviva, Inc. | 261.06 Million USD | 142.322% |
| Summit Therapeutics Inc. | -2.05 Million USD | -5289.707% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2623.732% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 612.829% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -93146.744% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -77002.742% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 18242.693% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 135.224% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 4392.502% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -217655.223% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1456.622% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -23183.145% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1062294.231% |
| Soligenix, Inc. | 97.31 Thousand USD | 113642.148% |
| Century Therapeutics, Inc. | -10.8 Million USD | -922.194% |
| Kura Oncology, Inc. | -849 Thousand USD | -12914.016% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -64.653% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -75062.585% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 211.561% |
| Autolus Therapeutics plc | -4.86 Million USD | -2170.166% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 366.972% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -65667.262% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 216.644% |
| GRI Bio, Inc. | 10.84 Million USD | 1119.177% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 4449.985% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1171.889% |
| IGM Biosciences, Inc. | -211.66 Million USD | 47.799% |
| INmune Bio, Inc. | 155 Thousand USD | 71383.226% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 278.384% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -7235.17% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -16938.834% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -377330.484% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 27584.826% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -5435.521% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -35200.0% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 216.968% |
| Verastem, Inc. | -62 Thousand USD | -178108.065% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 4637.536% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -42232.95% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 3750.116% |
| Histogen Inc. | 3.76 Million USD | 3031.52% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 19276.159% |
| Surrozen, Inc. | -27.23 Million USD | -305.762% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1950.269% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -9070.125% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -330.807% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 651.012% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -5580152.525% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1921.32% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -164487.15% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 171.379% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 75881.207% |
| Apollomics, Inc. | 127 Thousand USD | 87099.213% |
| Amarin Corporation plc | 165.54 Million USD | 166.744% |
| Mesoblast Limited | -9.81 Million USD | -1025.716% |
| Turnstone Biologics Corp. | 16.5 Million USD | 769.387% |
| Synaptogenix, Inc. | -6347.00 USD | -1740706.68% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -216545.098% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 168.471% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 106.286% |
| Better Therapeutics, Inc. | -2.72 Million USD | -3948.699% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1.491% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 132.681% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -968422.09% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1665.0% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -9871.931% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1609.825% |
| Insmed Incorporated | 239.63 Million USD | 146.107% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 3188.01% |
| OmniAb, Inc. | 14.66 Million USD | 853.317% |
| Alector, Inc. | -95.05 Million USD | -16.239% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 187.954% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -154.214% |
| Zai Lab Limited | 170.9 Million USD | 164.65% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 234.945% |
| Aura Biosciences, Inc. | -1.29 Million USD | -8431.969% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 85091.538% |
| Immunic, Inc. | -111 Thousand USD | -99439.64% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 796.916% |
| Veracyte, Inc. | 248.14 Million USD | 144.525% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.419% |
| FibroGen, Inc. | 128.9 Million USD | 185.714% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -19590148.227% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -847.031% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 103.251% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 28503.342% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 131.093% |
| TG Therapeutics, Inc. | 219.1 Million USD | 150.427% |
| Galecto, Inc. | -830 Thousand USD | -13211.928% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -7877.545% |
| Fortrea Holdings Inc. | 424 Million USD | 126.059% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -28.227% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -19386.596% |
| XBiotech Inc. | -1.74 Million USD | -6235.378% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -9871.931% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -137.759% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -46.277% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 250.524% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 757.555% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 128.4% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -122.549% |
| Vaxxinity, Inc. | -2.23 Million USD | -4845.792% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 133.814% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -875.72% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 551.879% |
| NexImmune, Inc. | -1.02 Million USD | -10679.709% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 2046192.593% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1454.944% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.978% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -165235.867% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -3011.49% |
| Ainos, Inc. | -253.73 Thousand USD | -43445.38% |
| Pluri Inc. | 322 Thousand USD | 34413.354% |
| Prothena Corporation plc | -129.2 Million USD | 14.483% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 319.12% |
| Celularity Inc. | 6.75 Million USD | 1735.662% |
| Rallybio Corporation | -150 Thousand USD | -73559.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -238.851% |
| MeiraGTx Holdings plc | 287 Thousand USD | 38597.909% |
| Omeros Corporation | -69.77 Million USD | -58.341% |
| Humacyte, Inc. | -76.55 Million USD | -44.336% |
| Immunocore Holdings plc | 248.39 Million USD | 144.482% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -628.387% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 277.117% |
| Blueprint Medicines Corporation | 236.58 Million USD | 146.702% |
| CalciMedica, Inc. | -58 Thousand USD | -190398.276% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -7648.177% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 480.275% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -3784.986% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -257.975% |
| Pulmatrix, Inc. | -8.22 Million USD | -1244.148% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -9343.504% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -27591.479% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 72.294% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 4080.746% |
| Cytokinetics, Incorporated | -322.59 Million USD | 65.75% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 12916.188% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -32301.466% |
| Vor Biopharma Inc. | -3.49 Million USD | -3064.061% |
| Roivant Sciences Ltd. | 109.23 Million USD | 201.148% |
| Evogene Ltd. | 1.39 Million USD | 7997.713% |
| ProKidney Corp. | -3.16 Million USD | -3386.557% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -151.615% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1711.331% |
| CorMedix Inc. | -205.56 Thousand USD | -53649.72% |
| BioLineRx Ltd. | 1.1 Million USD | 10071.931% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -40.444% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -334715.152% |
| Atai Life Sciences N.V. | -5000.00 USD | -2209680.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -90569.544% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -114992.708% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -7854.572% |
| Sagimet Biosciences Inc. | 2 Million USD | 5624.45% |
| MediciNova, Inc. | 979.7 Thousand USD | 11377.783% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -31.037% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -116751.568% |
| GeoVax Labs, Inc. | -20.72 Million USD | -433.228% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 145.183% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2530.064% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 112.666% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1587.867% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -35541.613% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -920641.667% |
| Absci Corporation | -41.84 Million USD | -164.018% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2209680.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -44.67% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -4389.598% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 151.694% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -11641.658% |
| Allakos Inc. | -6.14 Million USD | -1699.202% |
| Imunon, Inc. | -720 Thousand USD | -15245.588% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -60.138% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 123.217% |
| BioAtla, Inc. | -103.73 Million USD | -6.515% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -968422.09% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -61972.472% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 54.497% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -35427.01% |
| XOMA Corporation | 3.86 Million USD | 2961.668% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -57.65% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 846.85% |
| aTyr Pharma, Inc. | -2.38 Million USD | -4526.843% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 986.75% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -380896.552% |
| Viridian Therapeutics, Inc. | -1 Million USD | -10861.21% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 849915484.615% |
| Akari Therapeutics, Plc | -4000.00 USD | -2762125.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 117.348% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 56845.999% |
| UroGen Pharma Ltd. | 73.35 Million USD | 250.628% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -313.909% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 951770.973% |
| Orgenesis Inc. | -5.72 Million USD | -1829.939% |
| Entera Bio Ltd. | -56 Thousand USD | -197201.786% |
| GH Research PLC | -315 Thousand USD | -34975.873% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -58359.788% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -20945.524% |
| Xencor, Inc. | -85.26 Million USD | -29.591% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -49900.226% |
| Replimune Group, Inc. | -2.65 Million USD | -4061.544% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -10935.26% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 162.127% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 56845.999% |
| Portage Biotech Inc. | -54 Thousand USD | -204509.259% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -116751.568% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -29207.427% |
| OncoCyte Corporation | 413 Thousand USD | 26852.785% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -2457942.269% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -49769719.82% |
| Purple Biotech Ltd. | -196 Thousand USD | -56271.939% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1332.036% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1229.513% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -957.821% |
| HilleVax, Inc. | -2.15 Million USD | -5024.722% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -113806.186% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -736296.961% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -16440.269% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -480286.957% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1471877.682% |
| Savara Inc. | -44.26 Million USD | -149.625% |
| Curis, Inc. | 9.81 Million USD | 1226.175% |
| Daré Bioscience, Inc. | 2.76 Million USD | 4089.461% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -88441.366% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -6290.341% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -48360.088% |
| BeiGene, Ltd. | 2.07 Billion USD | 105.315% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -3851.822% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 72.355% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 294.907% |
| Erasca, Inc. | -3.73 Million USD | -2860.584% |
| bluebird bio, Inc. | -4.03 Million USD | -2641.663% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -391455.036% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 105.802% |
| DBV Technologies S.A. | 15.72 Million USD | 802.499% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -391455.036% |
| Moderna, Inc. | 2.15 Billion USD | 105.127% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -11975.301% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1480.077% |
| Molecular Templates, Inc. | 50.39 Million USD | 319.246% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -20513.619% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 182.585% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1675.779% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -180.835% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 0.575% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2979.404% |
| MacroGenics, Inc. | 50.52 Million USD | 318.673% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1711.889% |
| Prime Medicine, Inc. | -147.9 Million USD | 25.297% |
| Aditxt, Inc. | -111.66 Thousand USD | -98851.281% |
| Adagene Inc. | 18.11 Million USD | 710.049% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 22741.189% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 178.807% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 170.002% |
| SciSparc Ltd. | 2.19 Million USD | 5131.375% |
| Vericel Corporation | 135.57 Million USD | 181.496% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -440991.461% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -356523.201% |
| Generation Bio Co. | -73.91 Million USD | -49.489% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -25183.524% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 302.29% |
| Invivyd, Inc. | -2.02 Million USD | -5348.176% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 63.273% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -106716.644% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 214.653% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 212.414% |
| ADMA Biologics, Inc. | 88.21 Million USD | 225.245% |
| Clene Inc. | 533 Thousand USD | 20829.644% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 558.286% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -11445.35% |
| GeoVax Labs, Inc. | -20.72 Million USD | -433.228% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 5657.797% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -56760.475% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 321.843% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1457.939% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -13116.388% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 232.457% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 151222.935% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 307.835% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 36.203% |
| Trevena, Inc. | 1.45 Million USD | 7693.746% |
| Surrozen, Inc. | -27.23 Million USD | -305.762% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -31200.0% |
| Cingulate Inc. | -582.91 Thousand USD | -18854.467% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -356316.129% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -460.886% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1459464.069% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -12441.317% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 116.232% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -11083.097% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -196004.15% |
| Kronos Bio, Inc. | 1.37 Million USD | 8153.134% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -105.883% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -37738.699% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -22526.63% |
| ImmunityBio, Inc. | -17.89 Million USD | -517.602% |
| Korro Bio, Inc. | -3.63 Million USD | -2943.774% |
| Kineta, Inc. | 5.43 Million USD | 2133.665% |
| BioVie Inc. | -229.37 Thousand USD | -48069.171% |
| Codexis, Inc. | 57.33 Million USD | 292.711% |
| Celularity Inc. | 6.75 Million USD | 1735.662% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2853.277% |
| Celcuity Inc. | -142.77 Thousand USD | -77288.424% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 218500.87% |
| Cibus, Inc. | 1.42 Million USD | 7869.972% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -29442.513% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -382.085% |
| IN8bio, Inc. | -2.5 Million USD | -4317.793% |
| Kodiak Sciences Inc. | -25.94 Million USD | -325.826% |
| Annexon, Inc. | -3.26 Million USD | -3281.971% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -5305.528% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -164.727% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 17363.906% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 114.192% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 163.883% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -5715.211% |
| Arcellx, Inc. | 108.27 Million USD | 202.041% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -241.342% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 239.499% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -422.357% |
| Moolec Science SA | -143.3 Thousand USD | -77000.59% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -161.092% |
| Geron Corporation | -123.5 Million USD | 10.537% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 3461.393% |
| Royalty Pharma plc | 1.79 Billion USD | 106.159% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -57.639% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -3058842.414% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 47849.912% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 0.83% |
| Humacyte, Inc. | -76.55 Million USD | -44.336% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -11540.542% |
| 89bio, Inc. | -273 Thousand USD | -40372.161% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -8689.897% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -12929.363% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -89728.455% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 9973.905% |
| Notable Labs, Ltd. | 113 Thousand USD | 97877.876% |
| Liquidia Corporation | 14.6 Million USD | 856.774% |
| Mustang Bio, Inc. | -2.22 Million USD | -4865.798% |
| Immunovant, Inc. | -231 Thousand USD | -47730.736% |
| Quantum-Si incorporated | 488 Thousand USD | 22741.189% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -98.868% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -368196.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 6033.888% |
| Acasti Pharma Inc. | -11 Thousand USD | -1004345.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -53897.957% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -16938.834% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 34.041% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 9838.317% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -28899.738% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -5542.952% |
| PepGen Inc. | -1.18 Million USD | -9231.841% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -86899.213% |
| United Therapeutics Corporation | 2.07 Billion USD | 105.338% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -382.548% |
| Solid Biosciences Inc. | -76.56 Million USD | -44.311% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -133691.458% |
| Immuneering Corporation | -764.13 Thousand USD | -14359.299% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 166840.613% |
| Belite Bio, Inc | -399 Thousand USD | -27591.479% |
| XOMA Corporation | 3.86 Million USD | 2961.668% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -451.452% |
| Bionomics Limited | -434.44 Thousand USD | -25331.984% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -10187.616% |
| uniQure N.V. | 2.21 Million USD | 5088.217% |
| Cassava Sciences, Inc. | -89.42 Million USD | -23.558% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -20.007% |
| Forte Biosciences, Inc. | -9000.00 USD | -1227555.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -13132.216% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -25183.524% |
| Altimmune, Inc. | -65.37 Million USD | -69.013% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 130.519% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -10187.616% |
| Compugen Ltd. | 31.45 Million USD | 451.261% |
| Peak Bio, Inc. | 367.76 Thousand USD | 30143.043% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 550.681% |
| Benitec Biopharma Inc. | 108 Thousand USD | 102404.63% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -141552.564% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -9084.456% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -5964.16% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -92747.899% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -9084.456% |
| Instil Bio, Inc. | -4.75 Million USD | -2223.15% |
| argenx SE | 1.1 Billion USD | 109.968% |
| Immunome, Inc. | -8.9 Million USD | -1140.474% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -5745.979% |
| Verona Pharma plc | -679.62 Thousand USD | -16157.372% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -63036.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | -4532.662% |
| CervoMed Inc. | -1.29 Million USD | -8441.025% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -4490.32% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -2212.937% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 4571.429% |
| Moolec Science SA | -143.3 Thousand USD | -77000.59% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -26978.646% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -4035.798% |
| AnaptysBio, Inc. | 14.78 Million USD | 847.507% |
| Design Therapeutics, Inc. | -537 Thousand USD | -20475.233% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -25775.644% |
| NeurAxis, Inc. | 2.15 Million USD | 5223.049% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 5248.602% |
| Lumos Pharma, Inc. | 2 Million USD | 5605.182% |
| Achilles Therapeutics plc | -4.73 Million USD | -2235.294% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -63036.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -104455.477% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 449.0% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 12916.188% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -10606.298% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -142.577% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 257051.163% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -13341.484% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -839609.682% |
| Palisade Bio, Inc. | 246 Thousand USD | 45014.228% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -334715.152% |
| Beam Therapeutics Inc. | -59.67 Million USD | -85.161% |
| Neurogene Inc. | -3.26 Million USD | -3287.155% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 179.297% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2892.66% |
| Sesen Bio, Inc. | 40 Million USD | 376.223% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -37101.684% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2643.68% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1055.018% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 884.723% |
| Athira Pharma, Inc. | -969 Thousand USD | -11302.374% |
| Vaccinex, Inc. | -16 Million USD | -590.384% |
| HCW Biologics Inc. | -574.82 Thousand USD | -19121.362% |
| XOMA Corporation | 3.86 Million USD | 2961.668% |
| Nektar Therapeutics | 53.47 Million USD | 306.606% |
| Arvinas, Inc. | 71.8 Million USD | 253.884% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -32.384% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -76.008% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -34213.354% |
| Rezolute, Inc. | -36 Thousand USD | -306813.889% |
| Clene Inc. | 533 Thousand USD | 20829.644% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -8604962.305% |
| BeyondSpring Inc. | 1.75 Million USD | 6410.051% |
| Synlogic, Inc. | -1.92 Million USD | -5642.672% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -298518.919% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1644.931% |
| Peak Bio, Inc. | 367.76 Thousand USD | 30143.043% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -482.656% |
| Krystal Biotech, Inc. | 47.6 Million USD | 332.095% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 178.31% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 2298.786% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -4167.271% |
| MannKind Corporation | 136.19 Million USD | 181.128% |
| Ikena Oncology, Inc. | -50.49 Million USD | -118.825% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 201.539% |
| Gossamer Bio, Inc. | -4.38 Million USD | -2419.704% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -43744.841% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2209680.0% |
| Legend Biotech Corporation | 140.92 Million USD | 178.4% |
| Mural Oncology plc | -2.56 Million USD | -4204.207% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -19952.45% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -110389.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 632.374% |
| REGENXBIO Inc. | 53.02 Million USD | 308.356% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1962.534% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -57334.178% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -6279.273% |
| Vaxart, Inc. | -60.76 Million USD | -81.836% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -41946.198% |
| Cellectis S.A. | 18 Thousand USD | 613927.778% |
| Longeveron Inc. | 221 Thousand USD | 50095.023% |
| Repare Therapeutics Inc. | -80.07 Million USD | -37.991% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 110.109% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -8438.563% |
| Revolution Medicines, Inc. | -399.66 Million USD | 72.355% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -315582.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 225587.755% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.284% |
| Denali Therapeutics Inc. | -93.34 Million USD | -18.366% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -440991.461% |
| Veru Inc. | 7.56 Million USD | 1560.35% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -73071.523% |
| Cingulate Inc. | -582.91 Thousand USD | -18854.467% |
| Passage Bio, Inc. | -3.72 Million USD | -2869.336% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -917277.948% |
| Exicure, Inc. | -1.42 Million USD | -7664.512% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -28748.303% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 4187.643% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -21451.47% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 262.183% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -73752.828% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -86.618% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 28358.056% |
| OmniAb, Inc. | 14.66 Million USD | 853.317% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 652.638% |
| Lipocine Inc. | -2.85 Million USD | -3775.695% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -5895.062% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1836.705% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -7235.17% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 246.701% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -169883.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 231.073% |
| Ocugen, Inc. | -33.53 Million USD | -229.454% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -3394.276% |
| Q32 Bio Inc. | 578 Thousand USD | 19215.744% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -41593.962% |
| Alumis Inc. Common Stock | -1.28 Million USD | -8505.062% |
| Equillium, Inc. | 35.95 Million USD | 407.272% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -6372.701% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 22167.832% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2672589.889% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -42559.846% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 26238.127% |
| Dominari Holdings Inc. | 2.03 Million USD | 5518.784% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -60121.506% |
| vTv Therapeutics Inc. | -13.59 Million USD | -712.718% |
| Bio-Techne Corporation | 773.07 Million USD | 114.292% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 737.964% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 123.978% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -9351.583% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -360.755% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1044.593% |
| Nkarta, Inc. | -5.86 Million USD | -1782.586% |
| BioCardia, Inc. | -7.24 Million USD | -1424.196% |
| Iterum Therapeutics plc | -1.75 Million USD | -6213.657% |